A new Canadian study included 32 patients with recurrent Clostridium difficile, a bacterial infection that causes severe diarrhea and can be life-threatening.
The infection can occur after people take antibiotics, which often wipe out "good" bacteria and leave the door open for harmful bacteria like C difficile to flourish in the gut.
Some patients in the study, were trapped in a cycle of antibiotic treatment and recurrent C difficile infection, said study researcher Dr Thomas Louie, professor of medicine at the University of Calgary in Alberta.
Just one participant appears to have had a recurrence, and this was after taking antibiotics for a separate infection, Louie said.
More From This Section
Poop transplants, formally known as fecal microbiota transplantation, have been previously shown to be an effective way to treat C difficile infections.
"Pills are a great option because they're easier for patients to take, [and] don't involve costly, invasive procedures," Louie said.
Also, some patients fail to respond to enemas (because of incontinence), and cannot tolerate nose tubes for medical reasons, he said.
The researchers made the pills by processing donor fecal matter until it contained only bacteria. Then, they put the bacteria into three-layer capsules that do not disintegrate until they are passed the stomach and into the small intestine, Louie said.
In the future, if researchers can discover which bacteria are mainly responsible for "curing" patients of C difficile, those bacteria could be grown in a lab and manufactured into pills, Louie said.